• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday

    3/24/23 10:59:26 AM ET
    $ADMA
    $AI
    $CVGW
    $GHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADMA alert in real time by email

    U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session.

    • NaaS Technology Inc. (NASDAQ:NAAS) shares jumped 25.7% to $5.24. NaaS Technology will hold an annual general meeting of shareholders on April 19, 2023.
    • GH Research PLC (NASDAQ:GHRS) rose 25.5% to $8.68.
    • ReNew Energy Global Plc (NASDAQ:RNW) jumped 14.2% to $5.01.
    • Calavo Growers, Inc. (NASDAQ:CVGW) rose 8.8% to $27.06.
    • Nano Dimension Ltd. (NASDAQ:NNDM) surged 8.5% to $2.6050. Nano Dimension will review its options relative to Stratasys and other strategic acquisition targets.
    • SmartRent, Inc. (NYSE:SMRT) rose 8.3% to $2.5350.
    • Reading International, Inc. (NASDAQ:RDIB) gained 8% to $22.14.
    • ADMA Biologics, Inc. (NASDAQ:ADMA) shares gained 6.8% to $3.3215 after the company reported better-than-expected Q4 sales results and issued FY23 revenue guidance above estimates.
    • Steelcase Inc. (NYSE:SCS) gained 5.7% to $8.05. Steelcase reported better-than-expected Q4 financial results and issued Q1 EPS and revenue guidance above estimates.
    • C3.ai, Inc. (NYSE:AI) gained 4.5% to $26.02 after JMP Securities maintained a Market Outperform rating on the stock and raised its price target from $27 to $28.

    Check This Out: Around $32M Bet On Southwest Gas? Check Out These 3 Stocks Insiders Are Buying

    Get the next $ADMA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADMA
    $AI
    $CVGW
    $GHRS

    CompanyDatePrice TargetRatingAnalyst
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    ReNew Energy Global plc
    $RNW
    10/29/2025$8.15Outperform → Neutral
    Mizuho
    GH Research PLC
    $GHRS
    10/13/2025$19.00Buy
    Needham
    C3.ai Inc.
    $AI
    8/13/2025Outperform → Perform
    Oppenheimer
    C3.ai Inc.
    $AI
    8/12/2025$17.00Outperform → Market Perform
    Northland Capital
    C3.ai Inc.
    $AI
    8/11/2025$13.00Neutral → Underperform
    DA Davidson
    GH Research PLC
    $GHRS
    6/4/2025$25.00Overweight
    Cantor Fitzgerald
    GH Research PLC
    $GHRS
    3/13/2025$32.00Buy
    Guggenheim
    More analyst ratings

    $ADMA
    $AI
    $CVGW
    $GHRS
    SEC Filings

    View All

    SEC Form 10-K filed by ADMA Biologics Inc

    10-K - ADMA BIOLOGICS, INC. (0001368514) (Filer)

    2/25/26 5:16:08 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    ADMA Biologics Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - ADMA BIOLOGICS, INC. (0001368514) (Filer)

    2/25/26 4:11:12 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    C3.ai Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities

    8-K - C3.ai, Inc. (0001577526) (Filer)

    2/25/26 4:10:30 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $ADMA
    $AI
    $CVGW
    $GHRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Martell Frank bought $103,244 worth of shares (50,000 units at $2.06) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    12/16/25 4:30:22 PM ET
    $SMRT
    EDP Services
    Technology

    Chief Executive Officer Martell Frank bought $103,458 worth of shares (50,000 units at $2.07) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    12/12/25 5:31:56 PM ET
    $SMRT
    EDP Services
    Technology

    Chief Executive Officer Martell Frank bought $120,540 worth of shares (60,000 units at $2.01) (SEC Form 4)

    4 - SmartRent, Inc. (0001837014) (Issuer)

    12/10/25 4:10:48 PM ET
    $SMRT
    EDP Services
    Technology

    $ADMA
    $AI
    $CVGW
    $GHRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ADMA
    $AI
    $CVGW
    $GHRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ADMA
    $AI
    $CVGW
    $GHRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    C3 AI to Present at Two Investor Conferences on March 2, 2026

    C3 AI (NYSE:AI), the Enterprise AI application software company, today announced that C3 AI CEO Stephen Ehikian will participate in fireside chats at the following investor conferences: The Citizens Technology Conference in San Francisco, CA. The fireside chat is scheduled for Monday, March 2, 2026, at 9:00 am PT. The Morgan Stanley Technology, Media & Telecom Conference in San Francisco, CA. The fireside chat is scheduled for Monday, March 2, 2026, at 10:00 am PT. Interested parties will be able to watch replays of the webcasts, which will be accessible on the C3 AI Investor Relations website (ir.c3.ai) following the event. About C3.ai, Inc. C3 AI is the Enterprise AI applicat

    2/26/26 9:00:00 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income(1) of $161 Million, Representing 35% Year-Over-Year Growth FY 2025 Adjusted EBITDA(2) of $231 Million, Representing 40% Year-Over-Year Growth Incoming CFO Appointment Expected to Further Enhance Financial Strategy, Working Capital Execution and Capital Allocation Discipline Advancing SG-001 Pipeline Program with Anticipated FDA Pre-IND Meeting in 2026; Potential Accelerated Path to Registrational Trial Ongoing Share Repurchases and Capital Structure to Increase Stockholder Value Reiterating Previo

    2/25/26 4:05:00 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency

    BEIJING, Feb. 20, 2026 /PRNewswire/ -- NaaS Technology Inc. (NASDAQ:NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that it has received written notification (the "MVLS Notice") from the Nasdaq Stock Market LLC ("Nasdaq") dated February 17, 2026, notifying the Company that it is currently not in compliance with the minimum market value of listing securities (the "MVLS") of US$35 million for continued listing of the Company's Class A ordinary shares on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(2) (the "MLVS Requirement"). Nasdaq calculates the MVLS based upon the most recent total shares outstanding mult

    2/20/26 4:10:00 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    C3.ai downgraded by Citizens

    Citizens downgraded C3.ai from Mkt Outperform to Mkt Perform

    2/26/26 7:10:22 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    ReNew downgraded by Mizuho with a new price target

    Mizuho downgraded ReNew from Outperform to Neutral and set a new price target of $8.15

    10/29/25 7:53:21 AM ET
    $RNW
    Electric Utilities: Central
    Utilities

    Needham initiated coverage on GH Research PLC with a new price target

    Needham initiated coverage of GH Research PLC with a rating of Buy and set a new price target of $19.00

    10/13/25 8:53:27 AM ET
    $GHRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    COO and SVP, Compliance Kestenberg-Messina Kaitlin M. covered exercise/tax liability with 8,161 shares, decreasing direct ownership by 1% to 572,160 units (SEC Form 4)

    4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)

    2/23/26 9:00:19 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Grossman Adam S covered exercise/tax liability with 24,793 shares, decreasing direct ownership by 1% to 2,259,586 units (SEC Form 4)

    4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)

    2/23/26 9:00:18 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CFO and Treasurer Tade Brad L. covered exercise/tax liability with 6,479 shares, decreasing direct ownership by 3% to 232,940 units (SEC Form 4)

    4 - ADMA BIOLOGICS, INC. (0001368514) (Issuer)

    2/23/26 9:00:18 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMA
    $AI
    $CVGW
    $GHRS
    Leadership Updates

    Live Leadership Updates

    View All

    ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income(1) of $161 Million, Representing 35% Year-Over-Year Growth FY 2025 Adjusted EBITDA(2) of $231 Million, Representing 40% Year-Over-Year Growth Incoming CFO Appointment Expected to Further Enhance Financial Strategy, Working Capital Execution and Capital Allocation Discipline Advancing SG-001 Pipeline Program with Anticipated FDA Pre-IND Meeting in 2026; Potential Accelerated Path to Registrational Trial Ongoing Share Repurchases and Capital Structure to Increase Stockholder Value Reiterating Previo

    2/25/26 4:05:00 PM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SmartRent Names Sangeeth Ponathil Chief Information Officer

    Proven technology leader to drive the Company's technology strategy SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart communities and smart operations solutions for the rental housing industry, today announced the appointment of Sangeeth Ponathil as Chief Information Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117547781/en/A proven executive leader with more than 25 years of experience guiding enterprise technology strategy, Sangeeth Ponathil will chart SmartRent's technology roadmap moving forward. His acumen in corporate digital transformation, infrastructure modernization

    11/17/25 4:15:00 PM ET
    $SMRT
    EDP Services
    Technology

    Mike Clayville Joins C3 AI Board of Directors

    C3 AI (NYSE:AI), the Enterprise AI application software company, today announced the appointment of Mike Clayville to its board of directors, effective November 9, 2025. Mr. Clayville brings over 30 years of enterprise software and cloud infrastructure expertise. Most recently, he served as Chief Customer Officer at Stripe. Before Stripe, he led global commercial sales at Amazon Web Services, overseeing operations serving millions of customers across 170 countries. Earlier in his career, Mr. Clayville held senior leadership roles at VMware, BEA Systems, Tivoli Systems, and IBM, leading large-scale digital transformation initiatives. "Mike has spent his career helping companies grow an

    11/13/25 9:00:00 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    $ADMA
    $AI
    $CVGW
    $GHRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:57:27 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:53:40 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:32:48 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    $ADMA
    $AI
    $CVGW
    $GHRS
    Financials

    Live finance-specific insights

    View All

    Calavo Growers to Report First Quarter 2026 Financial Results

    SANTA PAULA, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in sourcing, packing and distribution of fresh avocados, tomatoes, papayas and processing of guacamole and other avocado products, today announced that it plans to release financial results for the fiscal first quarter ended January 31, 2026, and file its Form 10-Q after the market closes on Thursday, March 12, 2026. About Calavo Growers, Inc.Calavo Growers, Inc. (NASDAQ:CVGW) is a global leader in the processing and distribution of avocados, tomatoes, papayas and guacamole. Calavo products are sold under the trusted Calavo brand name, proprietary sub-brands, private label and st

    2/19/26 5:30:11 PM ET
    $CVGW
    Specialty Foods
    Consumer Discretionary

    ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    RAMSEY, N.J. and BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report fourth quarter and full year 2025 financial results on February 25, 2026, after the U.S. financial markets close. ADMA's management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call seamlessly, participants are required to register for the call here to receive the dial

    2/18/26 7:00:00 AM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    ReNew Announces Results for the Third Quarter of Fiscal 2026 (Q3 FY26) and Nine Months of Fiscal 2026, both ended December 31, 2025

    ReNew Energy Global Plc ("ReNew" or "the Company") (NASDAQ:RNW, RNWWW)), a leading decarbonization solutions company, today announced its unaudited consolidated IFRS results for Q3 FY26 and nine months ended December 31, 2025. Operating Highlights: As of December 31, 2025, the Company's portfolio consisted of ~19.2 GWs (including 1.5 GW of BESS), compared to ~17.4 GWs as of December 31, 2024. In addition, the Company has 6.5 GW of solar module manufacturing facilities, a 2.5 GW solar cell manufacturing facility which is operational and a 4 GW solar cell manufacturing facility which is in the process of being built. The Company's commissioned capacity has increased 7% year-over-year

    2/16/26 3:40:00 AM ET
    $RNW
    Electric Utilities: Central
    Utilities